FDA Scientists Say Novavax’s Covid-19 Vaccine Is Effective, But Also Raise Concerns
June 3, 2022
(STAT News) – Scientists at the Food and Drug Administration said the Covid-19 vaccine developed by the biotech Novavax was effective at preventing disease but questioned how effective it is against currently circulating strains — and raised concerns about the potential for a rare side effect. Their analysis, laid out in briefing documents released Friday ahead of an advisory committee meeting on the vaccine, sent Novavax shares down more than 16%. The FDA’s scientists raised concerns, in particular, about the risk of myocarditis and pericarditis associated with the vaccines. (Read More)